No products in the cart.

Home / Human Rights / ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain.

ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain.

March 18, 2024 by Lezzie 0 comments Human Rights

ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain.

Monday 18 March, 2024
Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is announcing today the execution of a distribution agreement conferring to PALEX (https://www.palexmedical.com/) the rights to offer ABL Diagnostics products to laboratories in Spain…
Read More

PREVWeight loss caused by common diabetes drug tied to 'anti-hunger' molecule in study

NEXTGorano reservoir: Jeopardy for humans or sanctuary for wildlife?